The Role Of Local Anesthetics in the Management of Adverse Effects Associated With Intrauterine Device Application

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

80 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-01-20

Study Completion Date

2019-07-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients who visited our family planning clinic and opted for IUD application for contraception purposes were also offered NT/TLA treatments simultaneously. 40 patients who matched the inclusion criteria and received IUDs and NT/TLA treatments were included in the study group and 41 patients who only received IUDs were included in the control group. All patients received copper IUDs and none of them were on additional hormonal treatment. Before the insertion of IUD, women in the therapy group received NT treatment with 6ml of 1% procaine injected transvaginal into the cervix at 5 and 7 o'clock localizations. Following IUD insertion, another 6ml of 1% procaine was injected into the Frankenhauser ganglia bilaterally. A final dose of 8ml of 1% procaine was injected into the abdominal trigger points and intracutaneously into the L4-S4 dermatomes as quaddles.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Anesthetic Efficacy of Intrauterine Lidocaine for Removal of a "Lost" Intrauterine Device

NCT00308841

"Lost" IUD

COMPLETED PHASE1

Cervical Lidocaine-Prilocaine Cream vs Glyceryl Trinitrate Cream in Nulliparous Women With LNG-IUD Insertion

NCT04355598

Contraception

UNKNOWN PHASE4

The Role of Lidocaine Spray in Reducing Pain During Intrauterine Device Application

NCT07155785

Intrauterine Device Migration Pain

COMPLETED NA

Intracervical Lidocaine Gel for IUD Insertional Pain

NCT01214161

Pain

COMPLETED NA

Glyceryl Trinitrate Versus Lidocaine Cream for IUD Insertion

NCT02708251

IUD Insertion

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

IUD Contraception Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

IUD patients

80 patients who matched the inclusion criteria and received IUDs

with NT/TLA (NT or also referred to as therapy with local anesthetics (TLA) )

Intervention Type OTHER

Patients who visited our family planning clinic and opted for IUD application for contraception purposes were also offered NT/TLA treatments simultaneously. 40 patients who matched the inclusion criteria and received IUDs and NT/TLA treatments were included in the study group and 41 patients who only received IUDs were included in the control group. All patients received copper IUDs and none of them were on additional hormonal treatment. Before the insertion of IUD, women in the therapy group received NT treatment with 6ml of 1% procaine injected transvaginal into the cervix at 5 and 7 o'clock localizations.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

with NT/TLA (NT or also referred to as therapy with local anesthetics (TLA) )

Patients who visited our family planning clinic and opted for IUD application for contraception purposes were also offered NT/TLA treatments simultaneously. 40 patients who matched the inclusion criteria and received IUDs and NT/TLA treatments were included in the study group and 41 patients who only received IUDs were included in the control group. All patients received copper IUDs and none of them were on additional hormonal treatment. Before the insertion of IUD, women in the therapy group received NT treatment with 6ml of 1% procaine injected transvaginal into the cervix at 5 and 7 o'clock localizations.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

without NT/TLA (NT or also referred to as therapy with local anesthetics (TLA) )

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* not pregnant women
* healty women age between 18- 45 years old

Exclusion Criteria

* chronic diseases which could cause chronic pelvic pain such as endometriosis
* which makes them prone to infections such as diabetes mellitus
* complication had arised during the IUD insertion, such as uterine perforation

Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes